Chief Executive Officer, QuayPharma
In the last decade under Maireadh’s leadership Quay has expanded from 20 employees to almost 200. During that time, the company has added GMP manufacturing, has taken products through to commercial launch, become a global leader in the development and manufacture of Live Bio Therapeutics and won awards for export and innovation. During this significant growth Maireadh ensured Quay maintained the flexible, can do attitude that set the company apart from the beginning.
16 November 2020
BOOK YOUR PLACE NOW